Increased glutamine anabolism sensitizes non-small cell lung cancer to gefitinib treatment.

Wang, Liang; Peng, Wen; Wu, Tianming; Deng, Pengchi; Zhao, Ying-Lan

Wang, Liang; Peng, Wen; Wu, Tianming; Deng, Pengchi; Zhao, Ying-Lan.

Afiliação

Wang L; 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, and Collaborative Innovation Center for Biotherapy, Sichuan University, 17#, 3rd Section, Renmin South Road, Chengdu, 610041 China.
Peng W; 2Institute of Biotechnology, University of Helsinki, P.O. Box 56, 00014 Helsinki, Finland.
Wu T; 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, and Collaborative Innovation Center for Biotherapy, Sichuan University, 17#, 3rd Section, Renmin South Road, Chengdu, 610041 China.
Deng P; Department of Oncology, The People's Hospital of Guizhou Province, 83#, Zhong Shan East Road, Guiyang, 550004 China.
Zhao YL; 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, and Collaborative Innovation Center for Biotherapy, Sichuan University, 17#, 3rd Section, Renmin South Road, Chengdu, 610041 China.

Cell Death Discov ; 4: 24, 2018.

Article em En | MEDLINE | ID: mdl-30109143

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Idioma: En Revista: Cell Death Discov Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google